INHIBITION OF c-myc GENE EXPRESSION IN MURINE
Wehave shown that geldanamycin (GDM), an antibiotic of benzoquinoid ansamycin group, inhibits DNAreplication in cultured mouse lymphoblastoma L5178Y cells. Here we report that GDM selectively inhibited the expression of c-myc gene, proto-oncogene, along with suppression of DNAreplication in L5178Ycells, which are consistent with our previous results that c-myc protein promotes cellular DNAreplication. The significantly enhanced inhibition by GDM of DNAreplication was observed, when the antibiotic was introduced at Gl stage prior to S phase of cell cycle. The results are in favor of the prospects that GDM inhibits DNAreplication mainly at time of initiation, and that c-myc protein is essential for the initiation of cellular DNAreplication. Furthermore, whenc-myc expression was inhibited by GDM,the expression of p53 gene, the product of which may be another DNA replication protein, was stimulated in the tumor cells. Thus, GDM should be useful to investigate the molecular mechanismof DNAreplication promoted by c-mycprotein and also to distinguish the function of c-myc protein from that of p53 protein in DNAreplication.
In recent years, the screening program of anticancer agents has been addressed to searching for inhibitors of oncogene function. Some antibiotics which inhibit oncogene function including genestein1} and erbstatin2) have been isolated under the program. It is worth asking as to whether the agent active against tumor cells inhibits the oncogene function or the expression of oncogene. We have previously reported that geldanamycin (GDM) which is active against eukaryotic cells including fungi, protozoa and tumor cells3) preferentially inhibits DNAreplication in cultured tumor cells4>5\ Our results have shown that the antibiotic profoundly blocks the progression from Gl to S phase of cell cycle followed by the inhibition of DNAreplication in cultured mouse lymphoblastoma L5178Y cells. These results lead us to the possibility that the initiation ofDNAreplication is a target of GDM.
Wehave recently shown that c-myc protein localized in nuclei is functioning as an initiator of DNA replication in mouseand humancells6>7). To improve our understanding the modeof action and antitumor activity of the antibiotic, we asked whether GDMinhibits the function of c-myc protein or the expression of c-myc gene. The cells were synchronized by the treatment with colcemid as described previously8). The cells arrested at metaphase divided within 1.5 hours after removal of colcemid, and enter S phase around 2 hours.
Hybridization of RNAwith Gene Probes The cultured L5178Y cells (5 x 105 cells/ml) of 30 ml culture were collected and washed once with PBS containing 2 mMEDTA.Total RNAwas prepared by the guanidine-cesium chloride method as described previously9-*.
The RNAwas separated on 1.4% agarose gel containing formamide, transferred to nitrocellulose filter, and hybridized with 32P-labeled gene probes according to the procedure described previously10).
Results

Effect of GDMon DNAReplication in L5178Y Cells
We have previously shown that GDMinhibits preferentially DNAsynthesis, but not overall protein and RNAsyntheses in cultured L5178Y cells4>5). Furthermore, the inhibition of DNAsynthesis by the antibiotic was greater at high rates of DNAreplication, suggesting that the antibiotic selectively inhibits initiation of DNAreplication4^. The rate of DNAreplication in random cultured L5178Y cells was gradually decreased for up to about 8 hours (the time assumed to correspond with the spun of S phase of cell cycle) in the presence of the antibiotic as demonstrated in Fig. 1 , suggesting that the antibiotic interrupts the progression from Gl to S phase of cell cycle. This speculation was supported by the following experiment. Significantly enhanced inhibition by GDMof DNAreplication was observed, when the antibiotic was introduced at Gl prior to the S phase of the cell cycle as presented in Fig. 2 . These results led us to postrate that the expression of the initiator protein for DNAreplication is suppressed in the presence of GDM.
Inhibition of c-myc Gene Expression by GDM Our recent findings indicate that c-myc protein localized in nuclei is functioning as an initiator of DNAreplication in mammaliancells6>7). Our concern has been focused on whether the antibiotic inhibits the function of c-myc protein or the expression of c-myc gene leading to the inhibition of DNA replication in L5178Y cells. The effect of GDMon gene expression of c-myc was investigated. The RNAtranscripts of c-myc in L5178Y cells treated with GDMfor 8 hours were markedly decreased ( Fig. 3A and B) , whereas no reduction of RNAtranscripts of hypoxanthine phosphoribosyltransferase (HPRT) gene which is the house keeping gene was detected in the presence of GDM (Fig. 3C) results from suppression of DNAreplication. In the effect of hydroxyurea (HU) on the c-myc gene L5178Ycells of randomor synchronized at Gl phase as described70 at the cell density of 5 x 104 per ml were preincubated with GDMfor 4 hours and pulse labeled with 1 /^Ci/ml of [3H]thymidine for 1 hour. The degree of incorporation was expressed by percentage of control. The [3H]thymidine incorporation of the control were 12,000 dpmfor random culture and 5,000 dpmfor synchronized culture per 5 x 104 cells, respectively. 
The amount of RNAtranscripts was detected by dot-blotting hybridization for c-myc (left), and for HPRT (right).
The amount of c-myctranscripts was detected by dot-blotting hybridization. The concentrations of ASMP-3 were enough to inhibit the cell growth.
affect the c-myc expression as previously reportedn). The simultaneous addition of HUand GDM to the cultured L5178Ycells suppressed the c-myc gene expression and also affected HPRTexpression to the same degree as GDMalone (Fig. 4) , indicating that the inhibition of c-myc gene expression by GDMis not influenced by suppression of DNAreplication. These results suggest that GDM inhibits the specific transcription process for c-myc gene expression in a direct or an indirect manner. Specific inhibition of c-myc gene expression by the antibiotic was also found in human leukemia HL60 cells (data not shown).
Stimulation of p53 Gene Expression by GDM The gene expression of p53 was apparently stimulated in the presence of GDM (Fig. 3D) . The reason for the enhanced gene expression of p53 remains obscure at present. Wehave previously shownthat p53 is also a DNAreplication protein and that p53 recognizes a different origin of DNA replication from that of c-myc protein12). So, it is possible that p53 was overexpressed by a SOS function in the presence of GDMgiven the defect of DNAreplication.
Effect of Other Antibiotics on c-myc Expression The suppression of c-myc gene was also examined using other antibiotics, HBM which is a benzoquinoid ansamycin (BQA) antibiotic, and ASMP-3 which is structurally analogous to BQA, but exhibits a different mode of action from BQAinterfering with microtuble assembly followed by mitosis inhibition1^. As shown in Fig. 5 , HBMinhibited the expression of c-myc gene, but ASMP-3 did not. Structural relationship among GDM,HBMand ASMP-3 will be discussed later.
Discussion
The studies in this manuscript show that the mode of inhibition of DNAreplication by GDM is due to the suppression of c-myc gene expression, which is based on our previous report that c-myc protein may be involved in the initiation of cellular DNAreplication6>7\ It is of our particular interest that GDMinhibits selectively c-myc gene expression, accompanied by the enhancement of p53 gene expression. It is possible that the p53 gene, the product of which is likely involved in DNA replication123 became overexpressed to exert a SOS function following the defect of DNAreplication, which resulted from inhibition of c-myc expression. Vast numbers of report have appeared that cmyc gene is overexpressed in cancer cells. So it is reasonable that antitumor activity of GDMis due to the suppression of c-myc gene expression followed by the inhibition of DNAreplication. The multiplication of cells is often induced by the signals, such as mitogen, onto cell surface leading the activation of proto-oncogenes. The constitutive expression of src or ras in cancer cells alters the cellular metabolismand then the cells moveto proliferation. Theexpression of oncogeneon cell surface induces the enhancement of phosphatidylinositol metabolism followed by high level of Cacation influx and then activation of protein kinase C (PKC)14). Several lines of evidence indicate that PKCis involved in the signal transduction from cell surface to nuclei, during which the target protein(s) is phosphorylated, leading DNAreplication. These lines of evidence lead us to have several possibilities concerning the mechanismof inhibition of c-myc gene expression by the antibiotic : The antibiotic might block the movement of signal of cell surface for activation of oncogene. The inhibition of activation of oncogenes on cell surface might result in alteration of PKCactivity followed by cmyc gene expression. This possibility may be supported by previous results that the antibiotic reduced the tyrosine phosphorylation of src gene product in v-src transformed cells15). It is also possible that the antibiotic directly inhibits the PKCactivity or the c-myc transcription. The c-myc protein is required both for the initiation of DNAreplication and the c-myc transcription itself, which suggests that the initiation of DNAreplication and c-myc expression are coordinately regulated. Andit was also reported that the binding sites of c-myc protein shares the sequences necessary for the initiation of DNAreplication and enhancer of c-myc transcription16).
Thus, the inactivation of c-myc protein or its expression should be followed by the inhibition of initiation of DNAreplication. It is likely that the mode of inhibition of DNAreplication by GDMis the primary inhibition of c-myc transcription. The blockade of c-myc expression by the antibiotic will give rise to the accelerated inhibition of c-myc gene expression because c-myc protein itself may be necessary for c-myc gene expression as we suggested16).
Although the mechanismof action of naphthoquinoid ansamycins, i.e. rifampicin and streptovaricins, has been extensively studied, and these antibiotics have become known as specific inhibitor of RNAsynthesis in prokaryote interacting with RNApolymerase17), the molecular mechanism of action of BQAantibiotics remains to be determined. The mode of action of benzenoid ansamycins which do not contain benzoquinoid ring, i.e. ASMP-313) and maytansine18) has been revealed to inhibit mitosis by interacting with tublin molecule. The structural differences among GDM,HBM and ASMP-3 are shown in Fig. 6 . Wepresented here the differences of the mode of action between these two groups of antibiotic on the c-myc expression in tumor cells. It has been reported that some inhibitors of c-myc expression including tumor necrosis factor19) , human interferon20) , neplanocin A21) , antipain22), 2-aminopurine23) and dimethyl sulfoxide11} induce the differentiation of cells. However, GDMdid not induce the differentiation of HL-60 cells. The results indicate that the inhibition of c-myc gene expression is not always necessary for differentiation of cells.
Molecular mechanisms of DNAreplication or differentiation of cells in eukaryote remain to be solved. To solve these, there exist possible strategies including in vitro system, mutational analysis in vivo, cloning of gene of interesting, and so on24). It is also useful to use inhibitors that work against DNAreplication255. Our study presented here should provide a basis for understanding the regulation of DNAreplication and the function of proto-oncogene products in regulation of cell proliferation in eukaryotes.
